Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Cervical Cancer
Interventions
DRUG

cisplatin

DRUG

paclitaxel

RADIATION

brachytherapy

RADIATION

radiation therapy

Trial Locations (13)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

27157

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

33136

University of Miami Sylvester Comprehensive Cancer Center, Miami

43210

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus

43214

Riverside Methodist Hospital Cancer Care, Columbus

44109

MetroHealth's Cancer Care Center at MetroHealth Medical Center, Cleveland

44111

Cleveland Clinic Cancer Center at Fairview Hospital, Cleveland

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

52242

Holden Comprehensive Cancer Center at University of Iowa, Iowa City

73104

Oklahoma University Medical Center, Oklahoma City

74104

Cancer Care Associates - Midtown Tulsa, Tulsa

60637-1470

University of Chicago Cancer Research Center, Chicago

08103

Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees, Camden

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00003377 - Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix | Biotech Hunter | Biotech Hunter